Conference Coverage
12 days ago
Elevate-Derm Summer Clinical PearlsLatest News
Nov 10, 2026 | News
Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year
Bimekizumab Sustains Joint Responses Through Week 24 in PsA
Nov 09, 2026
ATTO-1310 Reduces Itch at Week 12 in Chronic Pruritus and Atopic Dermatitis
Nov 06, 2026
Where Patients With Alopecia Areata Fit on the Path to Systemic Treatment
Nov 06, 2026
AADA Warns of 6% Medicare Payment Cut for Dermatologists in 2027
Nov 05, 2026
Videos
Advertisement
Shorts
1:00
Pearls and Advice From Horizons in Advanced Practice
11 days ago
by
Evangelia Nezis, MSN, APRN, FNP-BC
1:00
Keys to Success: Reading, Networking, Loving What You Do
11 days ago
by
Sharon Doering, PA-C
0:20
Don't Leave Home Without It: Conference Luggage Essentials
11 days ago
by
Evangelia Nezis, MSN, APRN, FNP-BC
0:57
How Biologics Prevent the Atopic March
12 days ago
by
Mark G. Lebwohl, MD
0:41
Advancing Patient Care Through Shared Medical Expertise
14 days ago
by
Douglas DiRuggiero, DMSc, MHS, PA-C
1:10
Why NPs and PAs Value the Horizons in Advanced Practice Meeting
15 days ago
by
Lakshi Aldredge, MSN, ANP-BC
1:40
Horizons in Advanced Practice: Advice for Dermatology NPs and PAs
16 days ago
by
Omar Noor, MD, FAAD(+2 more)
1:02
Lessons From Horizons in Advanced Practice
17 days ago
by
James Canner, PA-C
0:30
Live From Horizons in Advanced Practice 2026
18 days ago
by
Kaitlyn Bader, Assistant Managing Editor
0:27
Dermatology Times: Education for the Busy Clinician
18 days ago
by
Aaron S. Farberg, MD
Discover Dermatology Times NP/PA Connect™!
Connect With Dermatology Times® Wherever You Scroll
Dermatology Times Digital Edition
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.
Experts outline how to recognize undertreated psoriasis, assess incomplete response, and make individualized decisions when escalating therapy.
Experts discuss the Delphi consensus statement, which emphasizes early treatment and prioritizes JAK inhibitors as first-line therapy for adults with severe AA.
Explore trending plant oils in skincare and haircare, plus 2026’s hottest actives like ectoin and hypochlorous acid—balancing glow, barrier repair, and irritation risks.
The September issue highlights advances in alopecia areata, cosmetic SPF, psoriasis treatment, teledermatology, and atopic dermatitis.
SPD 2026 highlighted advances in pediatric dermatology spanning textured hair care, vitiligo, vascular anomalies, mental health, genetics, and collaborative care.
Tina Bhutani-Jacques, MD, explored how disease location, prior treatment response, and patient preference shape topical treatment decisions across 3 plaque psoriasis cases.
Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
Though convenient, SPF-infused cosmetics rarely deliver their labeled protection level in real-world use, underscoring the continued need for a dedicated broad-spectrum sunscreen as the foundation of any routine.
Clinicians can bridge the gap between online trends and evidence-based outcomes by leveraging patient curiosity, emphasizing ingredient transparency, and delivering personalized in-office care.
Continuing Medical Education
All News
Advertisement
Advertisement
Pediatric dermatologists outline how to evaluate suspected topical steroid withdrawal, exclude mimics, and preserve family trust in eczema care.
Diego Ruiz Dasilva, MD, and Lindsey Finklea, MD, discuss the burden of chronic inducible urticaria and phase 3 remIND findings for remibrutinib.
Doral Fredericks, PharmD, MBA, discusses how life stages, mental health, and reproductive concerns can shape dermatologic care for women.
Gaurav Singh, MD, MPH, explains how pharmacokinetics, trial design, and real-world tolerability set sonidegib apart from vismodegib in locally advanced basal cell carcinoma and when to start systemic therapy earlier.
Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
Dermatology Times is looking back on the top stories in dermatology from the month of October.
From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.
Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.
The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.
Advertisement
Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting CSU evidence.
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.
Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
Updated SKYRIZI labeling allows clinicians to use clinical judgment when determining the need for TB evaluation before treatment.
Experts outline how to recognize undertreated psoriasis, assess incomplete response, and make individualized decisions when escalating therapy.
Advertisement
Advertisement
Trending on Dermatology Times
1
Bimekizumab Sustains Joint Responses Through Week 24 in PsA
2
PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies
3
Where Patients With Alopecia Areata Fit on the Path to Systemic Treatment
4
Patient Perspective: Cost, Comorbidities, and Dosing in Psoriasis Care
5